|
HMGB3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65056857071022E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.44249065417534E-15 |
| Normal-vs-Stage2 |
4.85700000218969E-08 |
| Normal-vs-Stage3 |
1.73794312274822E-12 |
| Normal-vs-Stage4 |
1.038000E-02 |
| Stage1-vs-Stage2 |
7.920600E-01 |
| Stage1-vs-Stage3 |
9.341000E-01 |
| Stage1-vs-Stage4 |
5.779500E-02 |
| Stage2-vs-Stage3 |
8.420200E-01 |
| Stage2-vs-Stage4 |
7.935700E-02 |
| Stage3-vs-Stage4 |
6.653700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
3.194500E-02 |
| Normal-vs-Asian |
8.265600E-01 |
| Caucasian-vs-AfricanAmerican |
5.484800E-03 |
| Caucasian-vs-Asian |
1.698640E-01 |
| AfricanAmerican-vs-Asian |
2.683600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59428026336172E-13 |
| Normal-vs-Female |
1.67976743625786E-12 |
| Male-vs-Female |
9.953000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.858000E-02 |
| Normal-vs-Age(41-60Yrs) |
1.32209798664462E-11 |
| Normal-vs-Age(61-80Yrs) |
1.65101265992007E-12 |
| Normal-vs-Age(81-100Yrs) |
2.55349996702847E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.151420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.766200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.476140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.202400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.676000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.265000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.29249999994519E-06 |
| Normal-vs-Grade 2 |
3.99680288865056E-15 |
| Normal-vs-Grade 3 |
1.84607884534671E-12 |
| Normal-vs-Grade 4 |
6.741100E-03 |
| Grade 1-vs-Grade 2 |
6.435400E-01 |
| Grade 1-vs-Grade 3 |
4.437600E-01 |
| Grade 1-vs-Grade 4 |
5.263800E-02 |
| Grade 2-vs-Grade 3 |
7.007600E-01 |
| Grade 2-vs-Grade 4 |
4.525900E-02 |
| Grade 3-vs-Grade 4 |
7.648400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62458935193399E-12 |
| Normal-vs-ccB subtype |
3.59030000000038E-05 |
| ccA subtype-vs-ccB subtype |
1.76725301059832E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.53730036980926E-10 |
| Normal-vs-N1 |
1.744160E-02 |
| N0-vs-N1 |
1.650190E-01 |
|
|
